XML 72 R62.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segments of Business - Reportable operating segment (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Sep. 30, 2020
Dec. 31, 2021
Dec. 31, 2020
Mar. 31, 2021
Segment revenues            
Total revenues $ 68,614 $ 62,599   $ 197,864 $ 179,086  
Segment operating profit (loss)            
Total operating profit (loss) 298 (7,362)   1,405 (6,050)  
Corporate income (expenses), net (195) (8,246)   (858) (8,462)  
Loss on debt extinguishment 0 0   (191) 0  
Interest expense (41) (55)   (135) (165)  
Income (loss) from continuing operations before income taxes 277 (7,363)   1,281 (6,063)  
Pre-tax credits related to LIFO accounting       (79) (115)  
Charge for remeasurement to fair value       1,271 0  
Restructuring, impairment, and related charges 18 40   208 156  
Goodwill impairment charge 0 0   0 69  
Net gain on settlement proceeds (7) (8,067)   (193) (7,936)  
Notes and Debentures Extinguished February 7 2018 | Term Loan            
Segment operating profit (loss)            
Loss on debt extinguishment       (191)    
European Businesses (Disposal Group)            
Segment operating profit (loss)            
Charge for remeasurement to fair value       517    
National Prescription Opioid Litigation            
Segment operating profit (loss)            
Pre-tax expenses related to estimated litigation liability       193   $ 8,100
Held-for-sale | U.K. Disposal Group (Disposal Group)            
Segment operating profit (loss)            
Charge for remeasurement to fair value 823     823    
Held-for-sale | European Businesses (Disposal Group)            
Segment operating profit (loss)            
Charge for remeasurement to fair value 879     1,400    
Held-for-sale | E.U. Businesses (Disposal Group)            
Segment operating profit (loss)            
Charge for remeasurement to fair value 26     517    
Operating Segments            
Segment operating profit (loss)            
Total operating profit (loss) 513 938   2,465 2,564  
Corporate            
Segment operating profit (loss)            
Restructuring, impairment, and related charges 9 20   90 60  
Gains associated with equity investments   30   104 89  
Corporate | National Prescription Opioid Litigation            
Segment operating profit (loss)            
Pre-tax expenses related to estimated litigation liability       193    
Corporate | Held-for-sale | E.U. Businesses (Disposal Group)            
Segment operating profit (loss)            
Charge for remeasurement to fair value (32)     117    
National Prescription Opioid Litigation | Corporate            
Segment operating profit (loss)            
Pre-tax expenses related to estimated litigation liability   (8,100)     (8,100)  
Litigation expense 33 34   104 118  
Shareholder Derivative Action, Insurance Proceeds | Corporate            
Segment operating profit (loss)            
Net gain on settlement proceeds         131  
U.S. Pharmaceutical            
Segment revenues            
Total revenues 55,041 49,495   158,471 142,232  
U.S. Pharmaceutical | Operating Segments            
Segment operating profit (loss)            
Total operating profit (loss) 744 635   $ 2,186 1,871  
Revenue derived from services, percentage (less than)       1.00%    
Pre-tax credits related to LIFO accounting 33 11   $ 79 115  
Restructuring, impairment, and related charges 3 6   25 18  
U.S. Pharmaceutical | Operating Segments | New York Opioid Tax Surcharge            
Segment operating profit (loss)            
Charge recorded related to Company's share of the litigation settlement         50  
U.S. Pharmaceutical | Antitrust Legal Settlements | Operating Segments            
Segment operating profit (loss)            
Company's shares of legal settlements       46    
Prescription Technology Solutions            
Segment revenues            
Total revenues 1,031 777   2,844 2,101  
Prescription Technology Solutions | Operating Segments            
Segment operating profit (loss)            
Total operating profit (loss) 129 114   $ 361 270  
Revenue derived from services, percentage (less than)       40.00%    
Restructuring, impairment, and related charges 0 0   $ 18 0  
Medical-Surgical Solutions            
Segment revenues            
Total revenues 3,082 3,054   8,734 7,388  
Medical-Surgical Solutions | Operating Segments            
Segment operating profit (loss)            
Total operating profit (loss) 308 260   $ 679 536  
Revenue derived from services, percentage (less than)       4.00%    
Inventory impairments and excess inventory   35   $ 164 49  
Restructuring, impairment, and related charges 1 (2)   9 4  
International (1)            
Segment revenues            
Total revenues 9,460 9,273   27,815 27,365  
Segment operating profit (loss)            
Restructuring, impairment, and related charges   131     189  
Impairment, Long-Lived Asset, Held-for-Use   115     115  
International (1) | Operating Segments            
Segment operating profit (loss)            
Total operating profit (loss) (668) (71)   $ (761) (113)  
Revenue derived from services, percentage (less than)       8.00%    
Restructuring, impairment, and related charges 5 16   $ 66 74  
Goodwill impairment charge     $ 69      
International (1) | Operating Segments | Held-for-sale | U.K. Disposal Group (Disposal Group)            
Segment operating profit (loss)            
Charge for remeasurement to fair value 787     787    
International (1) | Operating Segments | Held-for-sale | E.U. Businesses (Disposal Group)            
Segment operating profit (loss)            
Charge for remeasurement to fair value $ 58     400    
International (1) | Operating Segments | Disposed of by sale | Canadian Health Benefit Claims Management and Plan Administrative Services Business            
Segment operating profit (loss)            
Pre-tax gain on sale of business       $ 59    
International (1) | Operating Segments | Contributed to Joint Venture | German Pharmaceutical Wholesale Business            
Segment operating profit (loss)            
Charge for remeasurement to fair value   $ 47     $ 57